Latest filing published 09 Jul 2026 for NEUROCRINE BIOSCIENCES, INC., €1.6M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Darin Lippoldt: trading record in brief
Darin Lippoldt discloses dealings in Neurocrine Biosciences Inc to SEC (Form 4). Over a trading history stretching from 26 June 2026 to 9 July 2026, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 9 July 2026, reports a transaction of €1.6M in Neurocrine Biosciences Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Darin Lippoldt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$178.24CommonSEC144:0001950047-26-006987
1 of 1 declaration
